Medicine and Dentistry
Pediatrics
100%
Adolescent
43%
Disease
38%
Transplantation
27%
Drug Therapy
26%
Symptom
26%
Multiple Sclerosis
24%
Placebo
22%
Major Depressive Episode
22%
Liver Transplantation
20%
Asthma
19%
Infection
19%
Surgery
19%
Liver Graft
18%
Injury
16%
Cardiopulmonary Bypass
16%
Ischemia
15%
Extracorporeal Membrane Oxygenation
14%
Rating Scale
14%
Clinician
13%
Pediatrics Patient
13%
Heart Single Ventricle
13%
Fluoxetine
13%
Health Care Cost
12%
Antibiotics
12%
Allograft
11%
Emergency Department
11%
Medullary Sponge Kidney
10%
Antidepressant
10%
Serositis
10%
Thermal Burn
10%
Nephronophthisis
9%
Nephropathy
9%
Diagnosis
9%
Surgeon
9%
Cognitive Behavioral Therapy
9%
Autosomal Dominant Inheritance
9%
Treatment of Depression
8%
Clinical Trial
8%
Organ Transplantation
8%
Persistent Truncus Arteriosus
8%
near Infrared Spectroscopy
8%
Gastroesophageal Reflux
8%
Neuromyelitis Optica
7%
Bacillary Dysentery
7%
Tamm Horsfall Glycoprotein
7%
Neonate
7%
Heart Transplantation
7%
Norwood Procedure
7%
Primary Health Care
7%
Heart Surgery
7%
Adverse Event
7%
Neoplasm
6%
Epstein Barr Virus
6%
Burn
6%
Adolescent Depression
6%
Depression of Adolescent
6%
Kidney Graft
6%
Depression
6%
In Vitro
6%
Optical Coherence Tomography
6%
Attention Deficit Disorder
6%
Neonatal Infant
6%
Virus Infection
5%
Hypoplastic Left Heart Syndrome
5%
Neurologic Disease
5%
Infusion
5%
Symptomatic Treatment
5%
Bronchiolitis
5%
Pediatric Trauma
5%
Kidney Transplantation
5%
Triage
5%
Epileptic Absence
5%
Outpatient
5%
Erythromycin
5%
Cardioplegia
5%
Neurofibromatosis Type I
5%
Cystic Fibrosis
5%
Empyema
5%
Human Immunodeficiency Virus
5%
Meningitis
5%
Nissen Fundoplication
5%
Coronary Circulation
5%
Haplotype
5%
Haemophilus influenzae
5%
Anomalous Pulmonary Venous Connection
5%
Pulmonary Artery
5%
Selective Serotonin Reuptake Inhibitor
5%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
44%
Disease
37%
Fluoxetine
31%
Ampicillin
31%
Major Depression
28%
Multiple Sclerosis
26%
Infection
23%
Symptom
21%
Pharmacokinetics
21%
Clinical Trial
18%
Adverse Event
18%
Remission
16%
Antidepressant
16%
Burn
15%
Bacterial Meningitis
14%
Shigellosis
14%
Penicillin Derivative
14%
Injury
14%
Cefaclor
14%
Asthma
13%
Antibiotics
11%
Amoxicillin
11%
Inflammation
11%
Haemophilus Influenzae Type B
10%
Attention Deficit Disorder
9%
Meningitis
9%
Antibiotic Agent
9%
Lamb
9%
Sepsis
7%
Bipolar Disorder
7%
Mouse
7%
Myelooptic Neuropathy
7%
Psychopharmacology
7%
Shigella
7%
Haemophilus influenzae
7%
Antiinfective Agent
7%
Neoplasm
6%
Infectious Agent
6%
Escherichia coli
6%
Erythromycin
6%
Erythromycin Ethylsuccinate
6%
Immunoglobulin E
6%
Staphylococcus Aureus
6%
Drug Intolerance
6%
Tumor Necrosis Factor
6%
Chloramphenicol
6%
Cotrimoxazole
6%
Ischemia
6%
Erythromycin Estolate
6%
Urinary Tract Infection
6%
Adolescent Depression
6%
Selective Serotonin Reuptake Inhibitor
6%
Cefadroxil
5%
Gentamicin
5%
Cephalosporin Derivative
5%
Rifampicin
5%
Furazolidone
5%
Streptococcal Pharyngitis
5%
Ceftriaxone
5%
Ticarcillin
5%
Clinical Pharmacology
5%
Recurrent Disease
5%
Otitis Media
5%
Antibiotic Therapy
5%
Nephrolithiasis
5%
Gram Negative Bacterium
5%
Keyphrases
Major Depressive Disorder
32%
Fluoxetine
25%
Placebo
21%
Multiple Sclerosis
14%
Depressive Symptoms
14%
Depression in Adolescents
14%
Ampicillin
13%
Shigellosis
10%
Haemophilus Influenzae Type b
10%
Child Depression
9%
Cognitive Behavioral Therapy
9%
Depression in children
9%
Pediatric
9%
Pediatric Patients
8%
Antidepressants
8%
Suicidal Ideation
8%
Adolescents with Depression
8%
Depression Rating Scales
8%
Acute Treatment
8%
Escherichia Coli
7%
Uromodulin
7%
Remission
7%
Suicide Attempt
7%
Penicillin
7%
Neuromyelitis Optica
7%
Health Risk
7%
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO)
7%
Liver Transplantation
7%
Multiple Sclerosis Treatment
7%
Erythromycin
7%
Selective Serotonin Reuptake Inhibitors
7%
Depression Severity
6%
Adolescent Depression
6%
Depression Treatment
6%
Gastroesophageal Reflux
6%
Medication Management
6%
Cefaclor
6%
Haemophilus Influenzae
6%
Texas
6%
Lithium
6%
Suicidal Behavior
5%
Relapsing-remitting multiple Sclerosis
5%
Trimethoprim-sulfamethoxazole (TMP-SMX)
5%
Bipolar Disorder
5%
Shigella
5%
Neonatal Lambs
5%
Suicidality
5%
Furazolidone
5%
Randomized Placebo-controlled Trial
5%
Bacterial Meningitis
5%
Arginine
5%
Cephalosporins
5%
Hypothermic Ischemia
5%
Treatment Options
5%
Neuromyelitis Optica Spectrum Disorder (NMOSD)
5%
Remission Rate
5%
Pharmacotherapy
5%
T Cell Antigen Receptor
5%
Divalproex Sodium
5%
Burn Trauma
5%
Aquaporin-4 (AQP4)
5%
Intensive Outpatient Program
5%